The $3m from Novo was received some time ago now. The presentation summarises how the rights issue funds will be used.
However I am unclear why the terms of the option are already pre-determined (upfront, milestone, royalties), and yet Cbio is under no obligation to enter into a licence with NN, even if NN exercise their option (according to Lodge partners report anyway).
Also the milestone payments seem small compared to other players in this game. Maybe they are only for the phase 2b milestone(s).
- Forums
- ASX - By Stock
- Ann: Investor Presentation
The $3m from Novo was received some time ago now. The...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla